Kelly Chen

Kelly Chen is a highly accomplished professional with a strong educational background in biological engineering and biomedical/medical engineering.

She holds a Postdoc in Biological Engineering from the prestigious Massachusetts Institute of Technology (MIT), a Doctor of Philosophy (PhD) in Biomedical/Medical Engineering from the University of Toronto, and a Bachelor of Applied Science (BASc) in Chemical Engineering with a Bioengineering minor, also from the University of Toronto.

Kelly has held key positions in renowned organizations, currently serving as the Principal Scientist and Group Lead at Roche. Prior to this role, she worked as a Scientist at Amgen and as a Visiting Scientist at Boehringer Ingelheim. Additionally, she gained valuable experience as a Postdoc at MIT.

Her expertise and experience in the field of biological and medical engineering make her a valuable asset in driving innovation and research in the pharmaceutical and healthcare industries.